Sofina Covid Solidarity Fund

基金名称
Sofina Covid Solidarity Fund
资助机构
King Baudouin Foundation
地区
Belgium
研究领域
COVID-19
Digital Computers or Computing
Disease Prevention
Distance Learning
Infectious Diseases
Medical Devices
Minority Education
截止日期
June 30, 2022 (已过期)
基金规模
€500,000EUR Selected projects will receive a minimum amount of €500,000.
联系方式
Patricia Van Houtte vanhoutte.p@mandate.kbs-frb.be
covidsolidarity@sofinagroup.com
申请资格
All not-for-profit organizations setting up a project in Western Europe, India or Singapore and which fits with the key issues targeted by the Fund, may introduce an application. The project may be led jointly by teams from different institutions, but it must be submitted by a single project leader.
说明
In line with the aspirations of its stakeholders and the company's strategic direction, the Sofina Covid Solidarity Fund wishes to address the adverse consequences of the global Covid-19 pandemic on two key issues related to Sofina's focus sectors: specific challenges in healthcare systems and services and the digital gap in education. 1. Challenges to Healthcare Systems and Services The challenges the pandemic poses to healthcare systems globally are manifold and difficult to overcome. Related issues range from shortages of medical equipment and limited capacities to restricted access to healthcare professionals during the confinement period, which significantly increases the health risk for wide parts of the global population. The Fund will sponsor initiatives focusing on health prevention and facilitating access to the first line of care. It will direct its efforts towards populations and regions severely impacted by the crisis. 2. The Digital Gap in Education During the crisis, children across the globe are deprived of access to education. This worsens the inequalities in education outcomes for children from underprivileged backgrounds. In the current environment, digitalization is one of the solutions to bridge this educational gap. The Fund aims to help reducing this digital divide by supporting non-profit initiatives in the sector. Eligibility All not-for-profit organizations setting up a project in Western Europe, India or Singapore and which fits with the key issues targeted by the Fund, may introduce an application. The project may be led jointly by teams from different institutions, but it must be submitted by a single project leader.

基金资源

Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

June 30, 2022

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。


Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

相关基金

Australian National Aged Care Classification (AN-ACC) Transition Fund
Aged Care 30-Jun-2024 $55,440,000.00
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Health Sep 13, 2024 12:00:00 AM EDT $500,000
Leading Engineering for America's Prosperity, Health, and Infrastructure
Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)
Health Jan 17, 2025 12:00:00 AM EST $325,000
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Health May 28, 2025 12:00:00 AM EDT $1,500,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
Innovative Health Practices
Science and Technology and other Researc... Feb 20, 2028 12:00:00 AM EST $1,000,000,000